Safety Study of Filler Agent Composed of Umbilical Cord Mesenchymal Stem Cells and Hyaluronic Acid

Phase 1 Unknown 30 enrolled South China Research Center for Stem Cell and Regenerative Medicine

RandomizedParallel-groupDouble-blindTreatment

Summary

The overall goal of this study is to evaluate the safety and exploratory efficacy of the injectable filler agent composed of umbilical cord mesenchymal stem cells and hyaluronic acid for the improvement of wrinkles, acne, pitting scar and so on.

Timeline

Start: 2016-12
Primary completion: 2018-12
Completion: —

Drugs

Evaluation	Drug	Modality	Dose	Route
Comparator	Hyaluronic Acid	Other / unclassified	—	Other
Subject	mesenchymal stem cells	Cell therapy	—	Other

Indications

No indication recorded.